Literature DB >> 20159125

Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.

Anne E Holland1, Catherine J Hill, Tshepo Rasekaba, Annemarie Lee, Matthew T Naughton, Christine F McDonald.   

Abstract

OBJECTIVE: To establish the minimal important difference (MID) for the six-minute walk distance (6MWD) in persons with chronic obstructive pulmonary disease (COPD).
DESIGN: Analysis of data from an observational study using distribution- and anchor-based methods to determine the MID in 6MWD.
SETTING: Outpatient pulmonary rehabilitation program at 2 teaching hospitals. PARTICIPANTS: Seventy-five patients with COPD (44 men) in a stable clinical state with mean age 70 years (SD 9 y), forced expiratory volume in one second 52% (SD 21%) predicted and baseline walking distance 359 meters (SD 104 m).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Participants completed the six-minute walk test before and after a 7-week pulmonary rehabilitation program. Participants and clinicians completed a global rating of change score while blinded to the change in 6MWD.
RESULTS: The mean change in 6MWD in participants who reported themselves to be unchanged was 17.7 meters, compared with 60.2 meters in those who reported small change and 78.4 meters in those who reported substantial change (P=.004). Anchor-based methods identified an MID of 25 meters (95% confidence interval 20-61 m). There was excellent agreement with distribution-based methods (25.5-26.5m, kappa=.95). A change in 6MWD of 14% compared with baseline also represented a clinically important effect; this threshold was less sensitive than for absolute change (sensitivity .70 vs .85).
CONCLUSIONS: The MID for 6MWD in COPD is 25 meters. Absolute change in 6MWD is a more sensitive indicator than percentage change from baseline. These data support the use of 6MWD as a patient-important outcome in research and clinical practice. Copyright 2010 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20159125     DOI: 10.1016/j.apmr.2009.10.017

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  109 in total

1.  The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Milo A Puhan; Diana Lam; Robert A Wise
Journal:  Am J Respir Crit Care Med       Date:  2012-06-21       Impact factor: 21.405

2.  Sarcopenia with limited mobility: an international consensus.

Authors:  John E Morley; Angela Marie Abbatecola; Josep M Argiles; Vickie Baracos; Juergen Bauer; Shalender Bhasin; Tommy Cederholm; Andrew J Stewart Coats; Steven R Cummings; William J Evans; Kenneth Fearon; Luigi Ferrucci; Roger A Fielding; Jack M Guralnik; Tamara B Harris; Akio Inui; Kamyar Kalantar-Zadeh; Bridget-Anne Kirwan; Giovanni Mantovani; Maurizio Muscaritoli; Anne B Newman; Filippo Rossi-Fanelli; Giuseppe M C Rosano; Ronenn Roubenoff; Morris Schambelan; Gerald H Sokol; Thomas W Storer; Bruno Vellas; Stephan von Haehling; Shing-Shing Yeh; Stefan D Anker
Journal:  J Am Med Dir Assoc       Date:  2011-07       Impact factor: 4.669

3.  Feasibility and impacts of supervised exercise training in subjects with obesity awaiting bariatric surgery: a pilot study.

Authors:  A Baillot; W M Mampuya; E Comeau; A Méziat-Burdin; M F Langlois
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

4.  The self-reported Physical Activity Scale for the Elderly (PASE) is a valid and clinically applicable measure in lung cancer.

Authors:  Catherine L Granger; Selina M Parry; Linda Denehy
Journal:  Support Care Cancer       Date:  2015-03-26       Impact factor: 3.603

5.  Reply: FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Surya P Bhatt; MeiLan K Han
Journal:  Am J Respir Crit Care Med       Date:  2017-06-15       Impact factor: 21.405

Review 6.  Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

7.  The contribution of exercise testing in the prescription and outcome evaluation of exercise training in pulmonary rehabilitation.

Authors:  Carmen Stroescu; Diana Ionita; Alina Croitoru; Claudia Toma; Bianca Paraschiv
Journal:  Maedica (Buchar)       Date:  2012-01

8.  Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change.

Authors:  Jos Hendrikx; Jaap Fransen; Wietske Kievit; Piet L C M van Riel
Journal:  Qual Life Res       Date:  2014-09-25       Impact factor: 4.147

Review 9.  Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

Review 10.  Chronic obstructive pulmonary disease (COPD) evidentiary framework.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.